Ketone Supplementation in Individuals With PTSD

November 15, 2019 updated by: Augusta University

The Effects of Exogenous Ketone Supplementation or a Ketogenic Diet in Individuals With PTSD

The purpose of this study is to determine if a 6-week period of ketone salt supplementation affects physiological, emotional, cognitive, and/or behavioral health markers in individuals with PTSD.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Georgia
      • Augusta, Georgia, United States, 30909
        • Recruiting
        • Augusta University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosed with PTSD

Exclusion Criteria:

  • Pregnant, younger than 18 or older than 65

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 6-week ketone supplementation
Participants took a ketomax ketone salt supplementation for 6-weeks. They took 2 servings per day.
6-week supplementation with ketone salts
Placebo Comparator: 6-week placebo supplement
Participants took a placebo supplement for 6-weeks. The placebo was calorie, sodium, and flavor-matched to the experimental supplement.
Placebo was taken for 6-weeks and was calorie and flavor matched to the ketone salt supplement.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Comprehensive Metabolic Panel
Time Frame: Pre- and Post- 6-week supplemental period
Blood health marker
Pre- and Post- 6-week supplemental period
Change in Complete Blood Count
Time Frame: Pre- and Post- 6-week supplemental period
Blood health marker
Pre- and Post- 6-week supplemental period
Change in Cognitive Performance
Time Frame: Pre- and Post- 6-week supplemental period
ANAM test battery
Pre- and Post- 6-week supplemental period
Change in Blood Pressure
Time Frame: Pre- and Post- 6-week supplemental period
Cardiovascular health measure
Pre- and Post- 6-week supplemental period
Change in Urinalysis
Time Frame: Pre- and Post- 6-week supplemental period
Health measure
Pre- and Post- 6-week supplemental period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Insomnia
Time Frame: Pre- and Post- 6-week supplemental period
Insomnia Severity Questionnaire
Pre- and Post- 6-week supplemental period
Change in Emotional Health
Time Frame: Pre- and Post- 6-week supplemental period
Title: 12-Item Grit Scale; Construct: measures trait-level perserverance and passion for long-term goals; the scale for each question includes the following answers to check: Very much like me, mostly like me, somewhat like me, not much like me, not like me at all; Scoring: for questions 1, 4, 6, 9, 10, and 12 the following answers receive the associated number as a score: Very much like me (5), Mostly like me (4), Somewhat like me (3), Not much like me (2), Not like me at all (1). And questions 2, 3, 5, 7, 8, and 11 receive the following points for the checked answers: Very much like me (1 points), Mostly like me (2 points), Somewhat like me (3 points), Not much like me (4 points), Not like me at all (5 points). Add up all the points and divide by 12. The maximum score on this scale is 5 (extremely gritty) and the lowest score is 1 (not at all gritty).
Pre- and Post- 6-week supplemental period
Change in Emotional Health
Time Frame: Pre- and Post- 6-week supplemental period
Title: Visual Analog Scales; Construct: measures the intensity or frequency of various symptoms; the scale is numerical with numbers from 0 to 10 lined horizontally and 0 indicates no symptom at all, 5 indicated neutral, and 10 indicates the highest feeling of the symptom. Symptoms asked included Hunger (0=not hungry at all, 10= very hungry), Satiety (0=don't feel full at all, 10=very full) , Mood (0= feel very down, 10= feel wonderful), Energy (0= very tired, 10=very energized), Focus (0= very distracted, 10=very focused), Alertness (0=non-coherent, 10= very aware of my surroundings)
Pre- and Post- 6-week supplemental period
Change in Emotional Health
Time Frame: Pre- and Post- 6-week supplemental period
Mood Disorder Questionnaire
Pre- and Post- 6-week supplemental period
Change in alcohol use
Time Frame: Pre- and Post- 6-week supplemental period
Alcohol Use Disorders Questionnaire
Pre- and Post- 6-week supplemental period
Change in PTSD
Time Frame: Pre- and Post- 6-week supplemental period
PTSD Checklist for DSM-5
Pre- and Post- 6-week supplemental period
Change in PTSD
Time Frame: Pre- and Post- 6-week supplemental period
Patient Health Questionnaire-9
Pre- and Post- 6-week supplemental period
Change in pain
Time Frame: Pre- and Post- 6-week supplemental period
Pain Outcomes Questionnaire
Pre- and Post- 6-week supplemental period
Change in PTSD
Time Frame: Pre- and Post- 6-week supplemental period
Adverse Childhood Experience Questionnaire
Pre- and Post- 6-week supplemental period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 30, 2016

Primary Completion (Anticipated)

December 1, 2019

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

August 5, 2019

First Submitted That Met QC Criteria

September 5, 2019

First Posted (Actual)

September 10, 2019

Study Record Updates

Last Update Posted (Actual)

November 18, 2019

Last Update Submitted That Met QC Criteria

November 15, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 907405

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PTSD

Clinical Trials on Pruvit Ketomax Ketone Salt

3
Subscribe